Research programme: anti-B-cell receptor monoclonal antibodies - Genitope

Drug Profile

Research programme: anti-B-cell receptor monoclonal antibodies - Genitope

Alternative Names: Anti-BCR monoclonal antibodies; Non-Hodgkin's lymphoma therapeutics - Genitope

Latest Information Update: 24 Dec 2013

$50 / €47 *
* $ price applies to USA, Canada and Latin America. € price applies to the rest of the world. Final gross prices may vary according to local VAT.

At a glance

  • Originator Genitope Corporation
  • Class Monoclonal antibodies
  • Mechanism of Action B cell inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Non-Hodgkin's lymphoma

Most Recent Events

  • 11 Dec 2007 Preclinical pharmacodynamics data presented at the 49th Annual Meeting and Exposition of the American Society of Hematology (ASH-2007)
  • 05 Apr 2006 Preclinical trials in Non-Hodgkin's lymphoma in USA (IV-injection)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top